Brief: Microbot Medical Files FDA Pre-Submission Package For Regulatory Pathway For The Liberty Robotic System
31/03/2022 13:18
March 31 (Reuters) - Microbot Medical Inc MBOT.O :
* MICROBOT MEDICAL ACHIEVES SIGNIFICANT REGULATORY MILESTONE
FOR
THE LIBERTY ROBOTIC SYSTEM; FILES FDA PRE-SUBMISSION PACKAGE FOR
REGULATORY PATHWAY
* MICROBOT MEDICAL INC - EXPECTS TO MEET WITH FDA FOLLOWING
A
NORMAL REVIEW PROCESS TO DISCUSS PRE-SUBMISSION
Source text for Eikon: ID:nGNX5c4Ks3
Further company coverage: MBOT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones